Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2153730
Max Phase: Preclinical
Molecular Formula: C50H62N8O15
Molecular Weight: 1015.09
Molecule Type: Small molecule
Associated Items:
ID: ALA2153730
Max Phase: Preclinical
Molecular Formula: C50H62N8O15
Molecular Weight: 1015.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCc2cccc3c2oc2c(cccc23)CCNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
Standard InChI: InChI=1S/C50H62N8O15/c1-3-26(2)42-50(72)57-34(22-27-13-16-30(59)17-14-27)47(69)55-35(23-39(61)62)45(67)52-21-19-29-9-7-11-32-31-10-6-8-28(43(31)73-44(29)32)15-18-38(60)53-36(24-40(63)64)48(70)56-37(25-41(65)66)49(71)54-33(46(68)58-42)12-4-5-20-51/h6-11,13-14,16-17,26,33-37,42,59H,3-5,12,15,18-25,51H2,1-2H3,(H,52,67)(H,53,60)(H,54,71)(H,55,69)(H,56,70)(H,57,72)(H,58,68)(H,61,62)(H,63,64)(H,65,66)/t26-,33-,34-,35-,36-,37-,42-/m0/s1
Standard InChI Key: BSDCRCUNKKVJCD-GITVPZJDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1015.09 | Molecular Weight (Monoisotopic): 1014.4335 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gokhale A, Weldeghiorghis TK, Taneja V, Satyanarayanajois SD.. (2011) Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58., 54 (15): [PMID:21755948] [10.1021/jm200004e] |
Source(1):